Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Surg Oncol. 2019 Aug 21;120(6):1008–1015. doi: 10.1002/jso.25675

Table 1.

Type of Cancer and Incidence of BCIS in all patients.

Type of cancer N (%) (N=374) No BCIS N (%) (N=96) BCIS N (%) (N=278)
Breast cancer 63 (17%) 22 (23%) 41 (15%)
Sarcoma 55 (15%) 13 (14%) 42 (15%)
Other types of cancer 54 (14%) 11 (12%) 43 (15%)
Lung cancer 48 (13%) 9 (9%) 39 (14%)
Kidney cancer 45 (12%) 12 (13%) 33 (12%)
Prostate cancer 26 (7%) 6 (6%) 20 (7%)
Multiple myeloma 15 (4%) 4 (4%) 11 (4%)
Colorectal cancer 12 (3%) 4 (4%) 8 (3%)
Melanoma 11 (3%) 3 (3%) 8 (3%)
Lymphoma 10 (3%) 3 (3%) 7 (3%)
Endometrial cancer 9 (2%) 0 (0%) 9 (3%)
Thyroid cancer 7 (2%) 1 (1%) 6 (2%)
Leukemia 6 (1%) 3 (3%) 3 (1%)
Bladder cancer 5 (1%) 2 (2%) 3 (1%)
Uterine cancer 4 (1%) 3 (3%) 1 (0.3%)
Pancreatic cancer 2 (1%) 0 (0%) 2 (0.7%)
Ovarian cancer 2 (1%) 0 (0%) 2 (0.7%)

Other types of cancer included: neuroblastoma, hemangiopericytoma, paraganglioma, glioblastoma, CUP, gastric carcinoma, hepatocellular carcinoma, esophageal carcinoma, chordoma, carcinoid tumor, parotid gland mucoepidermoid carcinoma, squamous cell carcinoma, cholangiocarcinoma, germ cell tumor